Gene perturbation and intervention in probabilistic Boolean networks.

MOTIVATION A major objective of gene regulatory network modeling, in addition to gaining a deeper understanding of genetic regulation and control, is the development of computational tools for the identification and discovery of potential targets for therapeutic intervention in diseases such as cancer. We consider the general question of the potential effect of individual genes on the global dynamical network behavior, both from the view of random gene perturbation as well as intervention in order to elicit desired network behavior. RESULTS Using a recently introduced class of models, called Probabilistic Boolean Networks (PBNs), this paper develops a model for random gene perturbations and derives an explicit formula for the transition probabilities in the new PBN model. This result provides a building block for performing simulations and deriving other results concerning network dynamics. An example is provided to show how the gene perturbation model can be used to compute long-term influences of genes on other genes. Following this, the problem of intervention is addressed via the development of several computational tools based on first-passage times in Markov chains. The consequence is a methodology for finding the best gene with which to intervene in order to most likely achieve desirable network behavior. The ideas are illustrated with several examples in which the goal is to induce the network to transition into a desired state, or set of states. The corresponding issue of avoiding undesirable states is also addressed. Finally, the paper turns to the important problem of assessing the effect of gene perturbations on long-run network behavior. A bound on the steady-state probabilities is derived in terms of the perturbation probability. The result demonstrates that states of the network that are more 'easily reachable' from other states are more stable in the presence of gene perturbations. Consequently, these are hypothesized to correspond to cellular functional states. AVAILABILITY A library of functions written in MATLAB for simulating PBNs, constructing state-transition matrices, computing steady-state distributions, computing influences, modeling random gene perturbations, and finding optimal intervention targets, as described in this paper, is available on request from is@ieee.org.

[1]  P. Schweitzer Perturbation theory and finite Markov chains , 1968 .

[2]  S. Kauffman Metabolic stability and epigenesis in randomly constructed genetic nets. , 1969, Journal of theoretical biology.

[3]  L. Glass,et al.  The logical analysis of continuous, non-linear biochemical control networks. , 1973, Journal of theoretical biology.

[4]  Erhan Çinlar,et al.  Introduction to stochastic processes , 1974 .

[5]  P. J. Abrahams,et al.  In Vitro Transformation of Rat and Mouse Cells by DNA from Simian Virus 40 , 1975, Journal of virology.

[6]  R. Palmiter,et al.  Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors , 1984, Cell.

[7]  S. Kauffman,et al.  Towards a general theory of adaptive walks on rugged landscapes. , 1987, Journal of theoretical biology.

[8]  David E. Goldberg,et al.  Genetic Algorithms in Search Optimization and Machine Learning , 1988 .

[9]  Wen-Hwa Lee,et al.  SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene , 1988, Cell.

[10]  D. E. Goldberg,et al.  Genetic Algorithms in Search , 1989 .

[11]  C. Cole,et al.  The ability of simian virus 40 large T antigen to immortalize primary mouse embryo fibroblasts cosegregates with its ability to bind to p53 , 1991, Journal of virology.

[12]  Stuart A. Kauffman,et al.  The origins of order , 1993 .

[13]  C B Harley,et al.  Telomere loss: mitotic clock or genetic time bomb? , 1991, Mutation research.

[14]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.

[15]  L. Donehower,et al.  Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.

[16]  P. Friedman,et al.  Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53. , 1992, Genes & development.

[17]  J. Trent,et al.  WAF1, a potential mediator of p53 tumor suppression , 1993, Cell.

[18]  Scott W. Lowe,et al.  p53 is required for radiation-induced apoptosis in mouse thymocytes , 1993, Nature.

[19]  C B Harley,et al.  Specific association of human telomerase activity with immortal cells and cancer. , 1994, Science.

[20]  L. Altenberg The evolution of evolvability in genetic programming , 1994 .

[21]  J. K. Kinnear,et al.  Advances in Genetic Programming , 1994 .

[22]  Keiko Hiyama,et al.  Correlating telomerase activity levels with human neuroblastoma outcomes , 1995, Nature Medicine.

[23]  R Thomas,et al.  Dynamical behaviour of biological regulatory networks--I. Biological role of feedback loops and practical use of the concept of the loop-characteristic state. , 1995, Bulletin of mathematical biology.

[24]  John Calvin Reed,et al.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene , 1995, Cell.

[25]  E. Estey,et al.  Telomerase activity in human acute myelogenous leukemia: inhibition of telomerase activity by differentiation-inducing agents. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

[26]  Roland Somogyi,et al.  Modeling the complexity of genetic networks: Understanding multigenic and pleiotropic regulation , 1996, Complex..

[27]  John E. Myers,et al.  Discrete dynamics lab (DDLAB) , 1997 .

[28]  John E. Myers Discrete dynamics lab (DDLAB) , 1997, Complex..

[29]  H. Pass,et al.  Simian virus 40, poliovaccines and human tumors: a review of recent developments , 1997, Oncogene.

[30]  Wei Zhang,et al.  Differential p53 phosphorylation and activation of apoptosis-promoting genes Bax and Fas/APO-1 by irradiation and ara-C treatment , 1998, Cell Death and Differentiation.

[31]  Z. Szallasi,et al.  Modeling the normal and neoplastic cell cycle with "realistic Boolean genetic networks": their application for understanding carcinogenesis and assessing therapeutic strategies. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[32]  A Wuensche,et al.  Genomic regulation modeled as a network with basins of attraction. , 1998, Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing.

[33]  Sui Huang Gene expression profiling, genetic networks, and cellular states: an integrating concept for tumorigenesis and drug discovery , 1999, Journal of Molecular Medicine.

[34]  F. Khuri,et al.  Adenovirus-mediated p53 gene transfer in advanced non-small-cell lung cancer. , 1999, Journal of the National Cancer Institute.

[35]  K Sivakumar,et al.  General nonlinear framework for the analysis of gene interaction via multivariate expression arrays. , 2000, Journal of biomedical optics.

[36]  C. D. Meyer,et al.  Markov chain sensitivity measured by mean first passage times , 2000 .

[37]  E. Dougherty,et al.  Multivariate measurement of gene expression relationships. , 2000, Genomics.

[38]  Edward R. Dougherty,et al.  Coefficient of determination in nonlinear signal processing , 2000, Signal Process..

[39]  International Human Genome Sequencing Consortium Initial sequencing and analysis of the human genome , 2001, Nature.

[40]  S. Batalov,et al.  A Comparison of the Celera and Ensembl Predicted Gene Sets Reveals Little Overlap in Novel Genes , 2001, Cell.

[41]  K. Tabuchi,et al.  Detection of simian virus 40 DNA sequence in human primary glioblastomas multiforme. , 2001, Journal of neurosurgery.

[42]  Detecton of simian virus 40 DNA sequence in human primary glioblastomas multiforme , 2001 .

[43]  J. V. Moran,et al.  Initial sequencing and analysis of the human genome. , 2001, Nature.

[44]  Edward R. Dougherty,et al.  Probabilistic Boolean networks: a rule-based uncertainty model for gene regulatory networks , 2002, Bioinform..